10 studies found for:    Open Studies | "Poxviridae Infections"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Condition: Smallpox
Intervention:
2 Unknown  Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium;   Drug: Placebo
3 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
4 Recruiting Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
5 Recruiting A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Intervention: Biological: GL-ONC1
6 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
7 Recruiting Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
Condition: Cancer of Head and Neck
Intervention: Biological: GL-ONC1
8 Not yet recruiting A Dose Range-Finding Phase 2 Trial of a Botanical Drug for the Treatment of Molluscum Contagiosum in Pediatric Subjects
Condition: Molluscum Contagiosum
Interventions: Drug: 2.5% East Indian sandalwood oil cream;   Drug: 5% East Indian sandalwood oil cream;   Drug: 10% East Indian sandalwood oil cream;   Drug: Placebo Cream
9 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
10 Not yet recruiting A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: Prevention in 18-40 Year Old Healthy Vaccinia-naïve Subjects
Interventions: Biological: MVA BN®;   Biological: ACAM2000

Indicates status has not been verified in more than two years